Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. The morbidity following treatment of [[incidental]] [[intracranial meningioma]] is not negligible. Considering most operated tumors are WHO grade I, treatment should be reserved for those manifesting symptoms or demonstrating substantial growth on radiological surveillance ((Islim AI, Mohan M, Moon RDC, Rathi N, Kolamunnage-Dona R, Crofton A, Haylock BJ, Mills SJ, Brodbelt AR, Jenkinson MD. Treatment outcomes of incidental intracranial meningiomas: Results from the IMPACT cohort. World Neurosurg. 2020 Mar 18. pii: S1878-8750(20)30529-5. doi: 10.1016/j.wneu.2020.03.060. [Epub ahead of print] PubMed PMID: 32200011. )). incidental_intracranial_meningioma.txt Last modified: 2024/06/07 02:52by 127.0.0.1